Skip to main content

Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder

Phase: PHASE1 | Sponsor: Trent Emerick | Compound: Psilocybin

Status
planned
Institution
Trent Emerick
Start date
2026-07-01
End date
2027-08-01
Registry ID
NCT07406828

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.